Qinghai Biotech Pharmaceutical Group Limited

HK$1.46As of Sun 8 Nov 2026, 12:00 UTC
HKEX:0876Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (25.79%)
Div yield —
ROE (71.79%)
Medical Instruments & Supplies
Beta (5Y) 1.11
PE TTM —
TSR TTM (69.58%)
Mkt cap HK$151.3M
ROIC (17.97%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.50
2.67%
(97.17%)
Hold 6|4|11|4|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.03
15.82%
3.40%
3.89%
16.93%
Revenue$M
10.59
11.05
11.24
11.90
(1.25%)
0.45%
3.78%
9.69%
Peers (US$19.30M)
Cap (US$)
PE
19.99M
1.661x
20.90M
13.85x
Capital
TTM
5Y
10Y
Leveragex
1.438
0.148
0.130
EBIT/Intx
1.956
0.487
0.478
Own earn%
58.34
(80.14)
(58.50)
Sh yield%
25.98
40.85
40.53
Owners
Insiders/Inst%
4.08
37.00
Short interest%
2.35
SBC / revenue%
0.56
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
11–17
$1 testx
—
Incr. ROIC%
2